NEW YORK (GenomeWeb) – CareDx said after the close of the market on Monday that its third quarter revenues were up 16 percent year over year.

The Brisbane, Calif.-based molecular diagnostics firm reported total revenues of $6.7 million for the three months ended September 30, up from $5.8 million in the year-ago quarter and just above the consensus analyst estimate of $6.6 million.

Testing revenue increased 16 percent year over year to $6.6 million from $5.7 million, while collaboration and license revenue decreased 42 percent to $53,000 from $91,000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Sponsored by

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Sponsored by

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.